rs11683248

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004304.5(ALK):​c.3068-415G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.338 in 151,836 control chromosomes in the GnomAD database, including 9,273 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 9273 hom., cov: 30)

Consequence

ALK
NM_004304.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.473

Publications

3 publications found
Variant links:
Genes affected
ALK (HGNC:427): (ALK receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
ALK Gene-Disease associations (from GenCC):
  • neuroblastoma, susceptibility to, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.381 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004304.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
NM_004304.5
MANE Select
c.3068-415G>C
intron
N/ANP_004295.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
ENST00000389048.8
TSL:1 MANE Select
c.3068-415G>C
intron
N/AENSP00000373700.3Q9UM73
ALK
ENST00000618119.4
TSL:5
c.1937-415G>C
intron
N/AENSP00000482733.1A0A087WZL3
ALK
ENST00000431873.6
TSL:5
n.233-415G>C
intron
N/AENSP00000414027.3E7EPW7

Frequencies

GnomAD3 genomes
AF:
0.338
AC:
51267
AN:
151718
Hom.:
9254
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.307
Gnomad AMI
AF:
0.283
Gnomad AMR
AF:
0.228
Gnomad ASJ
AF:
0.389
Gnomad EAS
AF:
0.0429
Gnomad SAS
AF:
0.330
Gnomad FIN
AF:
0.455
Gnomad MID
AF:
0.348
Gnomad NFE
AF:
0.385
Gnomad OTH
AF:
0.321
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.338
AC:
51296
AN:
151836
Hom.:
9273
Cov.:
30
AF XY:
0.336
AC XY:
24927
AN XY:
74186
show subpopulations
African (AFR)
AF:
0.307
AC:
12697
AN:
41386
American (AMR)
AF:
0.228
AC:
3473
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.389
AC:
1350
AN:
3472
East Asian (EAS)
AF:
0.0426
AC:
220
AN:
5168
South Asian (SAS)
AF:
0.333
AC:
1595
AN:
4796
European-Finnish (FIN)
AF:
0.455
AC:
4789
AN:
10536
Middle Eastern (MID)
AF:
0.333
AC:
98
AN:
294
European-Non Finnish (NFE)
AF:
0.385
AC:
26150
AN:
67904
Other (OTH)
AF:
0.317
AC:
666
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1657
3315
4972
6630
8287
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
512
1024
1536
2048
2560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.367
Hom.:
1353
Bravo
AF:
0.317
Asia WGS
AF:
0.165
AC:
574
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.2
DANN
Benign
0.33
PhyloP100
-0.47
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11683248; hg19: chr2-29448846; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.